title: Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient.
authors.forename: B
authors.initials: B
authors.lastname: Pellegrino
authors.forename: A
authors.initials: A
authors.lastname: Musolino
authors.forename: M
authors.initials: M
authors.lastname: Tiseo
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D003449:Cryoglobulinemia / Q000139:chemically induced / Q000276:immunology; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab